nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—IL1B—periodontitis	0.438	0.586	CbGaD
Minocycline—MMP9—periodontitis	0.309	0.414	CbGaD
Minocycline—IL1B—periosteum—periodontitis	0.0102	0.112	CbGeAlD
Minocycline—MMP9—periosteum—periodontitis	0.00852	0.0935	CbGeAlD
Minocycline—CASP3—tongue—periodontitis	0.00541	0.0594	CbGeAlD
Minocycline—CASP3—endothelium—periodontitis	0.00472	0.0518	CbGeAlD
Minocycline—CYCS—mouth—periodontitis	0.00425	0.0467	CbGeAlD
Minocycline—IL1B—endothelium—periodontitis	0.00377	0.0414	CbGeAlD
Minocycline—CASP3—mouth—periodontitis	0.00364	0.04	CbGeAlD
Minocycline—CYCS—neck—periodontitis	0.00363	0.0399	CbGeAlD
Minocycline—CASP1—trigeminal ganglion—periodontitis	0.00326	0.0358	CbGeAlD
Minocycline—MMP9—endothelium—periodontitis	0.00314	0.0345	CbGeAlD
Minocycline—CASP3—neck—periodontitis	0.00311	0.0342	CbGeAlD
Minocycline—IL1B—mouth—periodontitis	0.00291	0.0319	CbGeAlD
Minocycline—Doxycycline—MMP8—periodontitis	0.00272	0.591	CrCbGaD
Minocycline—CASP1—connective tissue—periodontitis	0.0027	0.0297	CbGeAlD
Minocycline—CYCS—connective tissue—periodontitis	0.0026	0.0286	CbGeAlD
Minocycline—CASP1—epithelium—periodontitis	0.00257	0.0282	CbGeAlD
Minocycline—CASP3—parotid gland—periodontitis	0.00253	0.0278	CbGeAlD
Minocycline—CYCS—epithelium—periodontitis	0.00247	0.0271	CbGeAlD
Minocycline—MMP9—mouth—periodontitis	0.00242	0.0266	CbGeAlD
Minocycline—CASP3—connective tissue—periodontitis	0.00223	0.0245	CbGeAlD
Minocycline—IL1B—trigeminal ganglion—periodontitis	0.00215	0.0236	CbGeAlD
Minocycline—CASP3—epithelium—periodontitis	0.00212	0.0232	CbGeAlD
Minocycline—VEGFA—trigeminal ganglion—periodontitis	0.00211	0.0232	CbGeAlD
Minocycline—MMP9—neck—periodontitis	0.00207	0.0227	CbGeAlD
Minocycline—Doxycycline—MMP1—periodontitis	0.00188	0.409	CrCbGaD
Minocycline—IL1B—connective tissue—periodontitis	0.00178	0.0196	CbGeAlD
Minocycline—IL1B—epithelium—periodontitis	0.00169	0.0186	CbGeAlD
Minocycline—MMP9—connective tissue—periodontitis	0.00148	0.0163	CbGeAlD
Minocycline—MMP9—epithelium—periodontitis	0.00141	0.0155	CbGeAlD
Minocycline—ALOX5—connective tissue—periodontitis	0.00117	0.0129	CbGeAlD
Minocycline—SLC22A8—trigeminal ganglion—periodontitis	0.000957	0.0105	CbGeAlD
Minocycline—IL1B—Allograft Rejection—TGFB1—periodontitis	0.000121	0.000771	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—IL1B—periodontitis	0.000121	0.000768	CbGpPWpGaD
Minocycline—VEGFA—Differentiation Pathway—TGFB1—periodontitis	0.00012	0.000765	CbGpPWpGaD
Minocycline—CASP1—Immune System—FCGR3A—periodontitis	0.00012	0.000763	CbGpPWpGaD
Minocycline—VEGFA—VEGFR2 mediated cell proliferation—IL6—periodontitis	0.00012	0.00076	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—periodontitis	0.000119	0.000758	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—TIMP1—periodontitis	0.000119	0.000757	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—TIMP1—periodontitis	0.000119	0.000756	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—TGFB1—periodontitis	0.000119	0.000754	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—CXCL8—periodontitis	0.000118	0.000751	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—MMP9—periodontitis	0.000118	0.00075	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IFNG—periodontitis	0.000117	0.000741	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—TNF—periodontitis	0.000116	0.000739	CbGpPWpGaD
Minocycline—MMP9—TWEAK Signaling Pathway—IL6—periodontitis	0.000116	0.000739	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—MMP9—periodontitis	0.000116	0.000737	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL1A—periodontitis	0.000116	0.000735	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL10—periodontitis	0.000115	0.000731	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—CCL2—periodontitis	0.000115	0.000728	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CD14—periodontitis	0.000114	0.000726	CbGpPWpGaD
Minocycline—CASP1—Signaling by Interleukins—IL6—periodontitis	0.000114	0.000724	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—MMP2—periodontitis	0.000114	0.000721	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—TNF—periodontitis	0.000113	0.00072	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—TNF—periodontitis	0.000113	0.00072	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	0.000112	0.000711	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—TNF—periodontitis	0.000111	0.000704	CbGpPWpGaD
Minocycline—MMP9—Endochondral Ossification—TGFB1—periodontitis	0.00011	0.0007	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—TGFB1—periodontitis	0.000109	0.000695	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL1A—periodontitis	0.000109	0.000692	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL18—periodontitis	0.000109	0.00069	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—CXCL8—periodontitis	0.000108	0.000689	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—MMP9—periodontitis	0.000107	0.000679	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP1—periodontitis	0.000107	0.000677	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TGFB1—periodontitis	0.000106	0.000675	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—IL6—periodontitis	0.000106	0.000671	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—CXCL8—periodontitis	0.000104	0.000663	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL1B—periodontitis	0.000104	0.000661	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—TNF—periodontitis	0.000104	0.000661	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—CXCL8—periodontitis	0.000104	0.000658	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—TGFB1—periodontitis	0.000103	0.000652	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IFNG—periodontitis	0.000102	0.000647	CbGpPWpGaD
Minocycline—IL1B—Immune System—CIITA—periodontitis	0.000102	0.000645	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	0.000102	0.000645	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—MMP1—periodontitis	0.0001	0.000638	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL1B—periodontitis	0.0001	0.000636	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TNF—periodontitis	9.92e-05	0.00063	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—VCAM1—periodontitis	9.88e-05	0.000627	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IFNG—periodontitis	9.75e-05	0.000619	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TGFB1—periodontitis	9.74e-05	0.000618	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TGFB1—periodontitis	9.67e-05	0.000614	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—TGFB1—periodontitis	9.57e-05	0.000608	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—CXCL8—periodontitis	9.45e-05	0.0006	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—IL1B—periodontitis	9.44e-05	0.0006	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—AGER—periodontitis	9.37e-05	0.000595	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—PTGS2—periodontitis	9.35e-05	0.000594	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP3—periodontitis	9.26e-05	0.000588	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—TNF—periodontitis	9.25e-05	0.000587	CbGpPWpGaD
Minocycline—CASP1—Immune System—FCGR2A—periodontitis	9.16e-05	0.000582	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	9.16e-05	0.000582	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—TNF—periodontitis	9.09e-05	0.000577	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL1B—periodontitis	9.09e-05	0.000577	CbGpPWpGaD
Minocycline—VEGFA—Differentiation Pathway—IL6—periodontitis	9.08e-05	0.000576	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—CXCL8—periodontitis	9.07e-05	0.000576	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TNF—periodontitis	9.06e-05	0.000575	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—FGF2—periodontitis	8.99e-05	0.000571	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—IL6—periodontitis	8.95e-05	0.000568	CbGpPWpGaD
Minocycline—IL1B—Immune System—CTSC—periodontitis	8.89e-05	0.000564	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TGFB1—periodontitis	8.81e-05	0.000559	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—TNF—periodontitis	8.78e-05	0.000557	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL1B—periodontitis	8.7e-05	0.000552	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—MMP9—periodontitis	8.54e-05	0.000542	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—SLC52A3—periodontitis	8.53e-05	0.000541	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—CXCL8—periodontitis	8.5e-05	0.00054	CbGpPWpGaD
Minocycline—IL1B—Immune System—LBP—periodontitis	8.42e-05	0.000535	CbGpPWpGaD
Minocycline—IL1B—Selenium Micronutrient Network—IL6—periodontitis	8.4e-05	0.000533	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP2—periodontitis	8.25e-05	0.000524	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—IL6—periodontitis	8.25e-05	0.000524	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TNF—periodontitis	8.23e-05	0.000522	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—CRP—periodontitis	8.17e-05	0.000519	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ACP5—periodontitis	8.16e-05	0.000518	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TGFB1—periodontitis	8.09e-05	0.000513	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—TGFB1—periodontitis	8.01e-05	0.000508	CbGpPWpGaD
Minocycline—CASP1—Immune System—CCR2—periodontitis	7.94e-05	0.000504	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL1RN—periodontitis	7.91e-05	0.000502	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—FGF2—periodontitis	7.84e-05	0.000498	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—TLR4—periodontitis	7.83e-05	0.000497	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—IL6—periodontitis	7.8e-05	0.000495	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—MET—periodontitis	7.76e-05	0.000492	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IL6—periodontitis	7.73e-05	0.000491	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—TGFB1—periodontitis	7.63e-05	0.000484	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL1A—periodontitis	7.6e-05	0.000483	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—TNF—periodontitis	7.55e-05	0.000479	CbGpPWpGaD
Minocycline—IL1B—Immune System—FCGR3A—periodontitis	7.51e-05	0.000477	CbGpPWpGaD
Minocycline—IL1B—Toll-like Receptor Signaling Pathway—IL6—periodontitis	7.46e-05	0.000474	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP1—periodontitis	7.4e-05	0.00047	CbGpPWpGaD
Minocycline—CASP1—Immune System—TLR2—periodontitis	7.38e-05	0.000469	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—FGF2—periodontitis	7.35e-05	0.000467	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TGFB1—periodontitis	7.34e-05	0.000466	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—IL6—periodontitis	7.34e-05	0.000466	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TNF—periodontitis	7.31e-05	0.000464	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—IL6—periodontitis	7.29e-05	0.000463	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—TNF—periodontitis	7.27e-05	0.000462	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—TNF—periodontitis	7.22e-05	0.000458	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—IL6—periodontitis	7.13e-05	0.000453	CbGpPWpGaD
Minocycline—ALOX5—Selenium Micronutrient Network—IL6—periodontitis	7.08e-05	0.00045	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL3—periodontitis	7.08e-05	0.000449	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD79A—periodontitis	6.94e-05	0.000441	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—PPARA—periodontitis	6.93e-05	0.00044	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TNF—periodontitis	6.85e-05	0.000435	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TGFB1—periodontitis	6.76e-05	0.000429	CbGpPWpGaD
Minocycline—CASP1—Immune System—CD14—periodontitis	6.66e-05	0.000423	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TGFB1—periodontitis	6.64e-05	0.000422	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—IL6—periodontitis	6.64e-05	0.000422	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	6.62e-05	0.00042	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—TNF—periodontitis	6.58e-05	0.000418	CbGpPWpGaD
Minocycline—CASP1—Immune System—VCAM1—periodontitis	6.42e-05	0.000408	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IFNG—periodontitis	6.37e-05	0.000404	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TNF—periodontitis	6.31e-05	0.000401	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—CXCL8—periodontitis	6.3e-05	0.0004	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—GGT1—periodontitis	6.28e-05	0.000399	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TNF—periodontitis	6.2e-05	0.000394	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP9—periodontitis	6.2e-05	0.000394	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	6.18e-05	0.000393	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TIMP1—periodontitis	6.14e-05	0.00039	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	6.12e-05	0.000389	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—FGF2—periodontitis	6.07e-05	0.000386	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL1B—periodontitis	6.04e-05	0.000383	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL6—periodontitis	5.87e-05	0.000373	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MET—periodontitis	5.83e-05	0.00037	CbGpPWpGaD
Minocycline—IL1B—Regulation of toll-like receptor signaling pathway—IL6—periodontitis	5.82e-05	0.00037	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP2—periodontitis	5.73e-05	0.000364	CbGpPWpGaD
Minocycline—IL1B—Immune System—FCGR2A—periodontitis	5.73e-05	0.000364	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL1A—periodontitis	5.69e-05	0.000361	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL18—periodontitis	5.68e-05	0.000361	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—PTGS2—periodontitis	5.52e-05	0.00035	CbGpPWpGaD
Minocycline—CASP1—Immune System—AGER—periodontitis	5.46e-05	0.000346	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—FGF2—periodontitis	5.44e-05	0.000346	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—IL6—periodontitis	5.34e-05	0.000339	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—IL6—periodontitis	5.32e-05	0.000338	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL6—periodontitis	5.31e-05	0.000337	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—VIP—periodontitis	5.12e-05	0.000325	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—TGFB1—periodontitis	5.11e-05	0.000325	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—IL6—periodontitis	5.09e-05	0.000323	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MET—periodontitis	5.06e-05	0.000321	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ACP5—periodontitis	5.03e-05	0.000319	CbGpPWpGaD
Minocycline—IL1B—Immune System—CCR2—periodontitis	4.96e-05	0.000315	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL1RN—periodontitis	4.94e-05	0.000314	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL3—periodontitis	4.91e-05	0.000312	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MMP2—periodontitis	4.86e-05	0.000309	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—IL6—periodontitis	4.78e-05	0.000304	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—IL6—periodontitis	4.77e-05	0.000303	CbGpPWpGaD
Minocycline—CASP1—Immune System—CRP—periodontitis	4.76e-05	0.000302	CbGpPWpGaD
Minocycline—IL1B—Immune System—TLR2—periodontitis	4.62e-05	0.000293	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—PPARA—periodontitis	4.57e-05	0.00029	CbGpPWpGaD
Minocycline—CASP1—Immune System—TLR4—periodontitis	4.56e-05	0.00029	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCR2—periodontitis	4.56e-05	0.00029	CbGpPWpGaD
Minocycline—CYCS—Metabolism—GGT1—periodontitis	4.54e-05	0.000288	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—IL6—periodontitis	4.51e-05	0.000287	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PPARA—periodontitis	4.49e-05	0.000285	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—IL6—periodontitis	4.42e-05	0.00028	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TNF—periodontitis	4.38e-05	0.000278	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD79A—periodontitis	4.34e-05	0.000276	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL3—periodontitis	4.26e-05	0.000271	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP2—periodontitis	4.22e-05	0.000268	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MET—periodontitis	4.16e-05	0.000264	CbGpPWpGaD
Minocycline—IL1B—Immune System—CD14—periodontitis	4.16e-05	0.000264	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—CXCL8—periodontitis	4.13e-05	0.000262	CbGpPWpGaD
Minocycline—IL1B—Immune System—VCAM1—periodontitis	4.01e-05	0.000255	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	3.99e-05	0.000253	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—PPARA—periodontitis	3.97e-05	0.000252	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—MMP1—periodontitis	3.82e-05	0.000242	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	3.73e-05	0.000237	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—IL6—periodontitis	3.61e-05	0.000229	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MET—periodontitis	3.61e-05	0.000229	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—PPARA—periodontitis	3.6e-05	0.000228	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL1A—periodontitis	3.56e-05	0.000226	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—TGFB1—periodontitis	3.55e-05	0.000225	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—VIP—periodontitis	3.55e-05	0.000225	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL18—periodontitis	3.55e-05	0.000225	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—TGFB1—periodontitis	3.55e-05	0.000225	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCR2—periodontitis	3.55e-05	0.000225	CbGpPWpGaD
Minocycline—CASP1—Immune System—FGF2—periodontitis	3.54e-05	0.000225	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL6—periodontitis	3.54e-05	0.000225	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADRB1—periodontitis	3.53e-05	0.000224	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MMP2—periodontitis	3.47e-05	0.00022	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—NOS2—periodontitis	3.44e-05	0.000219	CbGpPWpGaD
Minocycline—IL1B—Immune System—AGER—periodontitis	3.41e-05	0.000217	CbGpPWpGaD
Minocycline—CASP1—Immune System—IFNG—periodontitis	3.33e-05	0.000211	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—IL6—periodontitis	3.33e-05	0.000211	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—FGF2—periodontitis	3.3e-05	0.000209	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—PPARA—periodontitis	3.26e-05	0.000207	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PPARA—periodontitis	3.25e-05	0.000206	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP9—periodontitis	3.17e-05	0.000201	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCR2—periodontitis	3.17e-05	0.000201	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—VIP—periodontitis	3.08e-05	0.000196	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP2—periodontitis	3.01e-05	0.000191	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—IL6—periodontitis	2.98e-05	0.000189	CbGpPWpGaD
Minocycline—IL1B—Immune System—CRP—periodontitis	2.97e-05	0.000189	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL1B—periodontitis	2.97e-05	0.000188	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	2.92e-05	0.000185	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NTRK1—periodontitis	2.89e-05	0.000184	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—FGF2—periodontitis	2.86e-05	0.000182	CbGpPWpGaD
Minocycline—IL1B—Immune System—TLR4—periodontitis	2.85e-05	0.000181	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GGT1—periodontitis	2.8e-05	0.000177	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCR2—periodontitis	2.75e-05	0.000174	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—PPARA—periodontitis	2.74e-05	0.000174	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP3—periodontitis	2.69e-05	0.000171	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCR2—periodontitis	2.46e-05	0.000156	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADRB1—periodontitis	2.45e-05	0.000156	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL6—periodontitis	2.32e-05	0.000147	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—PPARA—periodontitis	2.29e-05	0.000145	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—IL6—periodontitis	2.27e-05	0.000144	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP9—periodontitis	2.26e-05	0.000144	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGF2—periodontitis	2.21e-05	0.00014	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TGFB1—periodontitis	2.15e-05	0.000136	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCR2—periodontitis	2.14e-05	0.000136	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRB1—periodontitis	2.13e-05	0.000135	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS2—periodontitis	2.11e-05	0.000134	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFNG—periodontitis	2.08e-05	0.000132	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—periodontitis	2.01e-05	0.000127	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NTRK1—periodontitis	2.01e-05	0.000127	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PPARA—periodontitis	2e-05	0.000127	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—IL6—periodontitis	1.97e-05	0.000125	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TGFB1—periodontitis	1.87e-05	0.000118	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MMP3—periodontitis	1.87e-05	0.000118	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB1—periodontitis	1.83e-05	0.000116	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCL2—periodontitis	1.75e-05	0.000111	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—periodontitis	1.74e-05	0.000111	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NTRK1—periodontitis	1.74e-05	0.000111	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6—periodontitis	1.74e-05	0.00011	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6—periodontitis	1.62e-05	0.000103	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP3—periodontitis	1.62e-05	0.000103	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGF2—periodontitis	1.58e-05	0.0001	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6—periodontitis	1.41e-05	8.93e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CXCL8—periodontitis	1.38e-05	8.77e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—periodontitis	1.3e-05	8.26e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP9—periodontitis	1.25e-05	7.93e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL2—periodontitis	1.21e-05	7.7e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGF2—periodontitis	1.1e-05	6.96e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6—periodontitis	1.09e-05	6.9e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL2—periodontitis	1.05e-05	6.69e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TGFB1—periodontitis	1.03e-05	6.54e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CXCL8—periodontitis	9.59e-06	6.09e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGF2—periodontitis	9.52e-06	6.04e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CXCL8—periodontitis	8.33e-06	5.29e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6—periodontitis	7.76e-06	4.93e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP9—periodontitis	7.53e-06	4.78e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFB1—periodontitis	7.15e-06	4.54e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFB1—periodontitis	6.21e-06	3.94e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6—periodontitis	5.39e-06	3.42e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6—periodontitis	4.68e-06	2.97e-05	CbGpPWpGaD
